Tech Company Financing Transactions

Stemgent Funding Round

On 6/30/2008, Stemgent raised $14 million in financing from Morgenthaler Ventures and private investors.

Transaction Overview

Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4 Hartwell Pl.
Lexington, MA 02421
USA
Email Address
Overview
Stemgent advances stem cell science by providing proprietary reagents and tools developed and proven for reproducibility by some of the world's leading stem cell scientists.
Profile
Stemgent LinkedIn Company Profile
Social Media
Stemgent Company Twitter Account
Company News
Stemgent News
Facebook
Stemgent on Facebook
YouTube
Stemgent on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rama Modali
  Rama Modali LinkedIn Profile  Rama Modali Twitter Account  Rama Modali News  Rama Modali on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2008: Anasift Technology venture capital transaction
Next: 6/30/2008: Crescendo Bioscience venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary